Advertisement

SKIP ADVERTISEMENT
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.

Rep. Jennifer Wexton Announces Rare Neurological Disorder Diagnosis

Ms. Wexton, a Democrat who disclosed a Parkinson’s diagnosis in April, will not seek re-election after learning she has progressive supranuclear palsy, for which there is no effective treatment.

A woman with long blond hair and glasses stands in front of an easel with a placard that says “Loudoun Chamber: Be More. Together.”
Rep. Jennifer Wexton, Democrat of Virginia, said in a statement on Monday that she has progressive supranuclear palsy, which she described as “Parkinson’s on steroids.”Credit...Matthew Barakat/Associated Press

Representative Jennifer Wexton, Democrat of Virginia, announced on Monday that she would not seek re-election next year after receiving a diagnosis of a rare neurological disorder.

Ms. Wexton, 55, who represents a competitive district in the Virginia suburbs west of Washington, D.C., revealed in a statement that she has progressive supranuclear palsy, which she described in a statement as “Parkinson’s on steroids.”

“I’m heartbroken to have to give up something I have loved after so many years of serving my community,” she said.

Ms. Wexton was elected to represent Virginia’s 10th Congressional District in 2018, defeating a two-term Republican incumbent, Barbara Comstock, by 12 percentage points.

In April, Ms. Wexton announced that she had been diagnosed with Parkinson’s disease, saying at the time that it would not stop her from continuing to live her life, or pursuing her political career.

“I’m doing well, and I want to bring about as much good from this diagnosis as I can — including here in Congress,” Ms. Wexton wrote on X, the platform formerly known as Twitter.


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.

Advertisement

SKIP ADVERTISEMENT